Clinical Updates on Cardiomyopathies and Heart Failure
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 157
Special Issue Editor
Interests: clinical aspects; molecular genetics; cardiomyopathies; heart failure
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Scientific knowledge on the field of cardiomyopathies and heart failure is evolving at a breathtaking speed, as evidenced by the numerous guidelines recently published. In the first comprehensive guideline on cardiomyopathies, punlished in 2023 by the European Society of Cardiology (ESC), it was recognized that although there have been major advances in the genetics, diagnosis, and treatment of patients with cardiomyopathy over the last few years, there are a number of areas where robust evidence is still lacking. These topics require attention in future clinical research, including cardiomyopathy phenotypes, epidemiology, integrated patient management, patient pathway, genetics, and general principles in management.
The same is very much true for heart failure, as new evidence obtained from recent clinical trials necessitated the update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure in just two years. New discoveries present new challenges, and many areas still lack evidence, including definition and epidemiology, diagnosis, drug and device therapy of CHF, in addition to issues in advanced and acute heart failure.
This Special Issue of the Journal of Clinical Medicine will focus on clinical updates on cardiomyopathies and heart failure and welcomes both original research articles and review papers that deal with clinical advances in cardiomyopathies and heart failure.
Dr. Róbert Sepp
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- hypertrophic cardiomyopathy
- dilated cardiomyopathy
- arrhythmogenic right ventricular cardiomyopathy
- restrictive cardiomyopathy
- non-compact cardiomyopathy
- left ventricular non-compaction
- tako-tsubo cardiomyopathy
- cardiomyopathy phenocopies
- diagnosis
- epidemiology
- prognosis
- drug therapy
- device therapy
